Increased Soluble Epoxide Hydrolase Activity Positively Correlates with Mortality in Heart Failure Patients with Preserved Ejection Fraction: Evidence from Metabolomics

Product Description

Epoxyeicosatrienoic acid: A potential therapeutic target of heart failure with preserved ejection fraction - ScienceDirect

Role of Soluble Epoxide Hydrolase in Postischemic Recovery of Heart Contractile Function

A novel soluble epoxide hydrolase vaccine protects murine cardiac muscle against myocardial infarction

Inhibition of soluble epoxide hydrolase ameliorates hyperhomocysteinemia-induced hepatic steatosis by enhancing β-oxidation of fatty acid in mice

Discovery of Novel Soluble Epoxide Hydrolase Inhibitors as Potent Vasodilators

Soluble Epoxide Hydrolase Regulates Hydrolysis of Vasoactive Epoxyeicosatrienoic Acids

Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease

Epoxylipids and soluble epoxide hydrolase in heart diseases - ScienceDirect

Cellular and molecular pathobiology of heart failure with preserved ejection fraction

Epoxides are generated from arachidonic acid. Arachidonic acid is

Frontiers Role of Soluble Epoxide Hydrolase in Metabolism of PUFAs in Psychiatric and Neurological Disorders

Myocardial Metabolomics of Human Heart Failure With Preserved Ejection Fraction

Role of Soluble Epoxide Hydrolase in Postischemic Recovery of Heart Contractile Function

Functional and Metabolic Imaging in Heart Failure with Preserved Ejection Fraction: Promises, Challenges, and Clinical Utility

Deletion of soluble epoxide hydrolase suppressed chronic kidney disease-related vascular calcification by restoring Sirtuin 3 expression